Ardeshna KM et al. An Intergroup randomised trial of rituximab versus a watch and wait strategy In patients with Stage II, III, IV, asymptomatic, non-bulky follicular lymphoma (Grades 1, 2 and 3a). A preliminary analysis. Proc ASH 2010;Abstract 6.

Armes J et al. Patients' supportive care needs beyond the end of cancer treatment: A prospective, longitudinal survey. J Clin Oncol 2009;27(36):6172-9. Abstract

Cohen L et al. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004;100(10):2253-60. Abstract

Horning SJ et al. Interim positron emission tomography scans in diffuse large B-cell lymphoma: An independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood 2010;115(4):775-7. Abstract

Korfel A. Prevention of central nervous system relapses in diffuse large B-cell lymphoma: Which patients and how? Curr Opin Oncol 2011;[Epub ahead of print]. Abstract

Lopez-Guillermo A et al. Diffuse large B-cell lymphoma: Clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005;23(12):2797-804. Abstract

Palesh OG et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 2010;28(2):292-8. Abstract

Salles GA et al. Updated results of the PRIMA study confirm the benefit of 2-years rituximab maintenance In follicular lymphoma patients responding to immunochemotherapy. Proc ASH 2010;Abstract 1788.

ECOG-E3404: Response-adapted therapy for aggressive NHL based on early PET scanning. NCT00274924